Rock Springs Capital Management LP 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:10 pm Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Rock Springs Capital Management LP | 3,681,174 5.960% |
595,147 (+19.29%) |
Filing |
| 2023-02-14 2:54 pm Purchase |
2022-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Rock Springs Capital Management LP | 3,086,027 7.640% |
633,390 (+25.82%) |
Filing |
| 2022-04-25 3:05 pm Purchase |
2022-04-14 | 13G | Inozyme Pharma, Inc. INZY |
Rock Springs Capital Management LP | 2,452,637 6.120% |
2,452,637 (New Position) |
Filing |